Literature DB >> 20813891

Decreased neprilysin and pulmonary vascular remodeling in chronic obstructive pulmonary disease.

Marilee J Wick1, Erica J Buesing, Carol A Wehling, Zoe L Loomis, Carlyne D Cool, Martin R Zamora, York E Miller, Sean P Colgan, Louis B Hersh, Norbert F Voelkel, Edward C Dempsey.   

Abstract

RATIONALE: Studies with genetically engineered mice showed that decreased expression of the transmembrane peptidase neprilysin (NEP) increases susceptibility to hypoxic pulmonary vascular remodeling and hypertension; in hypoxic wild-type mice, expression is decreased early in distal pulmonary arteries, where prominent vascular remodeling occurs. Therefore, in humans with smoke- and hypoxia-induced vascular remodeling, as in chronic obstructive pulmonary disease (COPD), pulmonary activity/expression of NEP may likewise be decreased.
OBJECTIVES: To test whether NEP activity and expression are reduced in COPD lungs and pulmonary arterial smooth muscle cells (SMCs) exposed to cigarette smoke extract or hypoxia and begin to investigate mechanisms involved.
METHODS: Control and advanced COPD lung lysates (n = 13-14) were analyzed for NEP activity and protein and mRNA expression. As a control, dipeptidyl peptidase IV activity was analyzed. Lung sections were assessed for vascular remodeling and oxidant damage. Human pulmonary arterial SMCs were exposed to cigarette smoke extract, hypoxia, or H₂O₂, and incubated with antioxidants or lysosomal/proteasomal inhibitors.
MEASUREMENTS AND MAIN RESULTS: COPD lungs demonstrated areas of vascular rarification, distal muscularization, and variable intimal and prominent medial/adventitial thickening. NEP activity was reduced by 76%; NEP protein expression was decreased in alveolar walls and distal vessels; mRNA expression was also decreased. In SMCs exposed to cigarette smoke extract, hypoxia, and H₂O₂, NEP activity and expression were also reduced. Reactive oxygen species inactivated NEP activity; NEP protein degradation appeared to be substantially induced.
CONCLUSIONS: Mechanisms responsible for reduced NEP activity and protein expression include oxidative reactions and protein degradation. Maintaining or increasing lung NEP may protect against pulmonary vascular remodeling in response to chronic smoke and hypoxia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20813891      PMCID: PMC3056229          DOI: 10.1164/rccm.201002-0154OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  56 in total

Review 1.  Molecular pathogenesis of pulmonary arterial hypertension.

Authors:  Marlene Rabinovitch
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

Review 2.  Unique growth properties of neonatal pulmonary vascular cells: importance of time- and site-specific responses, cell-cell interaction, and synergy.

Authors:  E C Dempsey; M Das; M G Frid; K R Stenmark
Journal:  J Perinatol       Date:  1996 Mar-Apr       Impact factor: 2.521

3.  Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD.

Authors:  S Santos; V I Peinado; J Ramírez; T Melgosa; J Roca; R Rodriguez-Roisin; J A Barberà
Journal:  Eur Respir J       Date:  2002-04       Impact factor: 16.671

4.  Pulmonary artery remodeling modifies pulmonary hypertension during exercise in severe emphysema.

Authors:  K Kubo; R L Ge; T Koizumi; K Fujimoto; T Yamanda; M Haniuda; T Honda
Journal:  Respir Physiol       Date:  2000-03

5.  Neprilysin null mice develop exaggerated pulmonary vascular remodeling in response to chronic hypoxia.

Authors:  Edward C Dempsey; Marilee J Wick; Vijaya Karoor; Erica J Barr; Dustin W Tallman; Carol A Wehling; Sandra J Walchak; Sven Laudi; Mysan Le; Masahiko Oka; Susan Majka; Carlyne D Cool; Karen A Fagan; Dwight J Klemm; Louis B Hersh; Norma P Gerard; Craig Gerard; York E Miller
Journal:  Am J Pathol       Date:  2009-03       Impact factor: 4.307

6.  HIF-dependent induction of adenosine A2B receptor in hypoxia.

Authors:  Tianqing Kong; Karen A Westerman; Marion Faigle; Holger K Eltzschig; Sean P Colgan
Journal:  FASEB J       Date:  2006-11       Impact factor: 5.191

Review 7.  Impact of oxidative stress on lung diseases.

Authors:  Hee Sun Park; So Ri Kim; Yong Chul Lee
Journal:  Respirology       Date:  2009-01       Impact factor: 6.424

8.  The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblotting.

Authors:  Georgina M Aldridge; David M Podrebarac; William T Greenough; Ivan Jeanne Weiler
Journal:  J Neurosci Methods       Date:  2008-05-15       Impact factor: 2.390

9.  Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.

Authors:  A J Cohen; P A Bunn; W Franklin; C Magill-Solc; C Hartmann; B Helfrich; L Gilman; J Folkvord; K Helm; Y E Miller
Journal:  Cancer Res       Date:  1996-02-15       Impact factor: 12.701

Review 10.  International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states.

Authors:  R T Jensen; J F Battey; E R Spindel; R V Benya
Journal:  Pharmacol Rev       Date:  2007-11-30       Impact factor: 25.468

View more
  18 in total

1.  Role of neprilysin in airway inflammation induced by diesel exhaust emissions.

Authors:  Simon S Wong; Nina N Sun; Cynthia D Fastje; Mark L Witten; R Clark Lantz; Bao Lu; Duane L Sherrill; Craig J Gerard; Jefferey L Burgess
Journal:  Res Rep Health Eff Inst       Date:  2011-06

2.  Decreased neprilysin and pulmonary vascular remodeling in chronic obstructive pulmonary disease.

Authors:  Marilee J Wick; Erica J Buesing; Carol A Wehling; Zoe L Loomis; Carlyne D Cool; Martin R Zamora; York E Miller; Sean P Colgan; Louis B Hersh; Norbert F Voelkel; Edward C Dempsey
Journal:  Am J Respir Crit Care Med       Date:  2010-09-02       Impact factor: 21.405

3.  Loss of neutral endopeptidase activity contributes to neutrophil activation and cardiac dysfunction during chronic hypomagnesemia: Protection by substance P receptor blockade.

Authors:  I Tong Mak; Joanna J Chmielinska; Jay H Kramer; Christopher F Spurney; William B Weglicki
Journal:  Exp Clin Cardiol       Date:  2011

4.  Neprilysins: an evolutionarily conserved family of metalloproteases that play important roles in reproduction in Drosophila.

Authors:  Jessica L Sitnik; Carmen Francis; Korneel Hens; Roger Huybrechts; Mariana F Wolfner; Patrick Callaerts
Journal:  Genetics       Date:  2014-01-06       Impact factor: 4.562

5.  Circulating Neprilysin in Patients With Heart Failure and Preserved Ejection Fraction.

Authors:  Melissa A Lyle; Seethalakshmi R Iyer; Margaret M Redfield; Yogesh N V Reddy; G Michael Felker; Thomas P Cappola; Adrian F Hernandez; Christopher G Scott; John C Burnett; Naveen L Pereira
Journal:  JACC Heart Fail       Date:  2019-08-07       Impact factor: 12.035

Review 6.  Airway inflammation and hypersensitivity induced by chronic smoking.

Authors:  Yu Ru Kou; Kevin Kwong; Lu-Yuan Lee
Journal:  Respir Physiol Neurobiol       Date:  2011-03-10       Impact factor: 1.931

7.  Neprilysin regulates pulmonary artery smooth muscle cell phenotype through a platelet-derived growth factor receptor-dependent mechanism.

Authors:  Vijaya Karoor; Masahiko Oka; Sandra J Walchak; Louis B Hersh; York E Miller; Edward C Dempsey
Journal:  Hypertension       Date:  2013-02-04       Impact factor: 10.190

8.  Protection against vascular leak in neprilysin transgenic mice with complex overexpression pattern.

Authors:  Marilee J Wick; Zoe L Loomis; Julie W Harral; Mysan Le; Carol A Wehling; York E Miller; Edward C Dempsey
Journal:  Transgenic Res       Date:  2016-07-01       Impact factor: 2.788

Review 9.  A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?

Authors:  Gerald Maarman; Sandrine Lecour; Ghazwan Butrous; Friedrich Thienemann; Karen Sliwa
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

10.  Hypoxia increases membrane metallo-endopeptidase expression in a novel lung cancer ex vivo model - role of tumor stroma cells.

Authors:  Katharina Leithner; Christoph Wohlkoenig; Elvira Stacher; Jörg Lindenmann; Nicole A Hofmann; Birgit Gallé; Christian Guelly; Franz Quehenberger; Philipp Stiegler; Freyja-Maria Smolle-Jüttner; Sjaak Philipsen; Helmut H Popper; Andelko Hrzenjak; Andrea Olschewski; Horst Olschewski
Journal:  BMC Cancer       Date:  2014-01-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.